Hut 8's consensus analyst price target has jumped from $49.27 to $56.00 per share, reflecting renewed optimism fueled by recent research updates and sector momentum. This upward move comes as ...

Bay's stock price target has seen a modest uptick, with consensus analyst estimates moving from $91.55 to $94.93. This subtle shift reflects a mix of analyst optimism and healthy skepticism, fueled by ...

R K Handa [email protected] When you signed a contract promising a “home in a residential colony,” how comfortable are ...

Get key insights from Lument Finance Trust's Q3 2025 earnings call—discover strategies, risk management, and new growth opportunities.

Discover key takeaways from The RMR Group's Q4 2025 earnings call, including earnings guidance, REIT strategies, and market risks.

During National Community Foundation week, join us and help improve civic health in our New Jersey communities.

Explore the WHO's new guide on water safety, covering 70+ technologies from source protection to household treatment (HWTS). Learn about risk governance, institutional arrangements, and the ...

CoreWeave (NASDAQ:CRWV) reported Q3 results, and the numbers were impressive – revenue more than doubled from last year, and losses narrowed as ...

Circle reported financial results for the third quarter on Wednesday. The transcript from the earnings call has been provided below.

In the assessment of 12-month price targets, analysts unveil insights for CoreWeave, presenting an average target of $151.73, ...

Despite councils charging landlords hundreds of pounds for selective licensing schemes, the government claims councils should ...

Detailed price information for Collegium Pharma (COLL-Q) from The Globe and Mail including charting and trades.